Annual influenza vaccination should be offered to all CABG patients, unless contraindications exist (Class I; Level of Evidence B). Disclosures Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Alexander Kulik Boca Raton Regional Hospital AHA None None None None None AstraZeneca ticagrelor research study* Marc Ruel University of Ottawa Heart Institute None None None None None None None T. Bruce Ferguson East Carolina Heart Institute at ECU None None None None None None None Loren F. Hiratzka TriHealth Heart Institute at Bethesda North and Good Samaritan Hospitals None None None None None None None John S. Ikonomidis Medical University of South Carolina None None None None None None None Hani Jneid Baylor College of Medicine None None None None None None None Francisco Lopez-Jimenez Mayo Clinic None None None None None None None Sheila M. McNallan Mayo Clinic None None None None None None None Mahesh Patel Duke University None None None None None None None V ronique L. Roger Mayo Clinic None None None None None None None Frank W. Sellke Rhode Island Hospital/Brown Medical School None None None None None Boehringer Ingelheim, DSMB for clinical trial*; CSL Behring, adjudication committee for trial*; Stryker, advisory committee (pending)* None Domenic A. Sica Virginia Commonwealth University Health System None None None None None None None Lani Zimmerman University of Nebraska Medical Center None None None None None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. 